Share

Jameela Al Salman

M.D.

Associate Professor of Medicine, Arabian Gulf University

Chief of Medical Staff for Medical Departments in Salmaniya Medical Complex

Chairperson of the hereditary blood diseases , Salmaniya Medical Complex

Senior Consultant in Infectious Diseases, Internal Medicine, and Geriatric Medicine

Dr. Al Salman is an Associate Professor in the Arabian Gulf University and is involved in a wide range of educational and research activities. She published many articles in peer reviewed journals. She led several international, regional, and local committees and quality projects. She is also in editorial Board of the several Medical Journals.


She graduated with Honor from the medical school at Arabian Gulf University. Then she joined the Salmaniya Medical complex in 1996. She holds three American Board certifications: American Board in Internal Medicine, American Board in Geriatric Medicine, American Board in Infectious Diseases. Further, she has the board in infection control and recently the American board in medical quality. Dr. Al Salman has completed her residency and fellowship programs in the United States, where she finished the internal medicine residency in Eason, Hahnemann University, Pennsylvania, USA. Then she did a fellowship in geriatric medicine at Temple University in Pennsylvania, followed by a fellowship in infectious diseases at Yale University, New Haven, Connecticut, USA.


She is a member of the Strategic and Technical Advisory Group for Antimicrobial resistance (STAG-AMR) which is the principal advisory group to the World Health Organization (WHO) on antimicrobial resistance, and a member of WHO Infection control and prevention development guidelines for COVID-19. She has received several awards locally, regional, and internationally for her scientific contribution.

- Awarded by His Majesty the King for her achievements in improving the clinical services and for the achievement in the antibiotic stewardship program and received the medal of competency from the first degree from his majesty in the national day of the kingdom December 2016.

-  Awarded the first position for Prize Khalifa Bin Salman Al Khalifa the prime minister in Bahrain in its first version for Bahraini Doctor for the achievements in medical research and innovation 2020.

- Awarded for excellence award for Arabic women in medical field for 2020 from League of Arab states.

- Awarded for the program of antibiotic stewardship for the best governmental practices for 2016 by HE the prime Minister in kingdom of Bahrain in 2016.

Jameela Al Salman

M.D.

Associate Professor of Medicine, Arabian Gulf University

Chief of Medical Staff for Medical Departments in Salmaniya Medical Complex

Chairperson of the hereditary blood diseases , Salmaniya Medical Complex

Senior Consultant in Infectious Diseases, Internal Medicine, and Geriatric Medicine

Dr. Al Salman is an Associate Professor in the Arabian Gulf University and is involved in a wide range of educational and research activities. She published many articles in peer reviewed journals. She led several international, regional, and local committees and quality projects. She is also in editorial Board of the several Medical Journals.


She graduated with Honor from the medical school at Arabian Gulf University. Then she joined the Salmaniya Medical complex in 1996. She holds three American Board certifications: American Board in Internal Medicine, American Board in Geriatric Medicine, American Board in Infectious Diseases. Further, she has the board in infection control and recently the American board in medical quality. Dr. Al Salman has completed her residency and fellowship programs in the United States, where she finished the internal medicine residency in Eason, Hahnemann University, Pennsylvania, USA. Then she did a fellowship in geriatric medicine at Temple University in Pennsylvania, followed by a fellowship in infectious diseases at Yale University, New Haven, Connecticut, USA.


She is a member of the Strategic and Technical Advisory Group for Antimicrobial resistance (STAG-AMR) which is the principal advisory group to the World Health Organization (WHO) on antimicrobial resistance, and a member of WHO Infection control and prevention development guidelines for COVID-19. She has received several awards locally, regional, and internationally for her scientific contribution.

- Awarded by His Majesty the King for her achievements in improving the clinical services and for the achievement in the antibiotic stewardship program and received the medal of competency from the first degree from his majesty in the national day of the kingdom December 2016.

-  Awarded the first position for Prize Khalifa Bin Salman Al Khalifa the prime minister in Bahrain in its first version for Bahraini Doctor for the achievements in medical research and innovation 2020.

- Awarded for excellence award for Arabic women in medical field for 2020 from League of Arab states.

- Awarded for the program of antibiotic stewardship for the best governmental practices for 2016 by HE the prime Minister in kingdom of Bahrain in 2016.

Recent Publications

The Management of Patients at High Risk of Serious COVID-19 Disease: Optimising the Patient Pathway in the Middle East, Africa, and Eastern Europe

Published On 2024 May 23

Journal article

Introduction For patients at high risk of severe COVID-19 disease, antiviral therapeutic options are available to reduce the risk of hospitalization or death. Although many countries have developed national guidelines for COVID-19 management that include use of antiviral agents, it is unclear how these guidelines are used in daily clinical practice. This study aims to assess the management of high-risk COVID-19 patients in the Middle East, Africa, and Eastern Europe, with a focus on...


Evaluation of an adjusted MEWS (Modified Early Warning Score) for COVID-19 patients to identify risk of ICU admission or death in the Kingdom of Bahrain

Published On 2023 Sep 22

Journal article

CONCLUSION: Development of our new Adjusted MEWS score system by adding the additional elements of age, oxygen saturation, comorbidities, Body Mass Index (BMI) and duration of symptoms found to be very useful predictor tool for preadmission triaging of COVID patients based on their risk assessment to help clinician to decide on the appropriate placement to different level of isolation facilities.